News in brief - pp959 - 960

doi:10.1038/nbt0907-959

Full Text - News in brief | PDF (117 KB) - News in brief

Trends in biotech literature 2006 - p961

Gaspar Taroncher-Oldenburg & Andrew Marshall

doi:10.1038/nbt0907-961

Full Text - Trends in biotech literature 2006 | PDF (151 KB) - Trends in biotech literature 2006

Blooming biotech - pp963 - 965

Carol Potera

doi:10.1038/nbt0907-963

Abstract - Blooming biotech | Full Text - Blooming biotech | PDF (164 KB) - Blooming biotech

What pharma wants - pp967 - 969

Klaus Wilgenbus, Ray Hill, Alan Warrander, Sanjay Kakkar, Eva Steiness & Rainer Wessel

doi:10.1038/bioe.2007.2

PDF (217 KB) - What pharma wants

The other side of staying out of a BIND - p971

Christopher W.V. Hogue

doi:10.1038/nbt0907-971a

Full Text - The other side of staying out of a BIND | PDF (144 KB) - The other side of staying out of a BIND

The other side of staying out of a BIND - pp971 - 972

Kai Wang

doi:10.1038/nbt0907-971b

Full Text - The other side of staying out of a BIND | PDF (183 KB) - The other side of staying out of a BIND

The Genasense 'learning curve' - pp972 - 973

C. A. Stein

doi:10.1038/nbt0907-972

Full Text - The Genasense 'learning curve' | PDF (122 KB) - The Genasense 'learning curve'

Response to The Genasense 'learning curve' - p973

doi:10.1038/nbt0907-973a

Full Text - Response to The Genasense 'learning curve' | PDF (83 KB) - Response to The Genasense 'learning curve'

Ethical framework for previously collected biobank samples - pp973 - 976

Gert Helgesson, Joakim Dillner, Joyce Carlson, Claus R Bartram & Mats G Hansson

doi:10.1038/nbt0907-973b

Full Text - Ethical framework for previously collected biobank samples | PDF (207 KB) - Ethical framework for previously collected biobank samples

NIH forges R&D partnerships in developing countries - pp976 - 977

Luis A. Salicrup

doi:10.1038/nbt0907-976

Full Text - NIH forges R&D partnerships in developing countries | PDF (185 KB) - NIH forges R&D partnerships in developing countries

North–South partnerships—a study of Canadian firms - pp978 - 979

Andrew D Taylor, David Brook, David Watters, Elizabeth Dowdeswell, Abdallah S Daar & Peter A Singer

doi:10.1038/nbt0907-978

Full Text - North–South partnerships—a study of Canadian firms | PDF (120 KB) - North–South partnerships—a study of Canadian firms

Adding value to valuation - p980

doi:10.1038/nbt0907-980

Full Text - Adding value to valuation | PDF (90 KB) - Adding value to valuation

Gene patents and genetic testing in the United States - pp989 - 990

Roger D Klein

doi:10.1038/nbt0907-989

Abstract - Gene patents and genetic testing in the United States | Full Text - Gene patents and genetic testing in the United States | PDF (100 KB) - Gene patents and genetic testing in the United States

Recent patent applications in stem cell culture - p991

doi:10.1038/nbt0907-991

Full Text - Recent patent applications in stem cell culture | PDF (46 KB) - Recent patent applications in stem cell culture

Comparative analysis of the complete genome sequence of the plant growth–promoting bacterium Bacillus amyloliquefaciens FZB42 - pp1007 - 1014

Xiao Hua Chen, Alexandra Koumoutsi, Romy Scholz, Andreas Eisenreich, Kathrin Schneider, Isabelle Heinemeyer, Burkhard Morgenstern, Björn Voss, Wolfgang R Hess, Oleg Reva, Helmut Junge, Birgit Voigt, Peter R Jungblut, Joachim Vater, Roderich Süssmuth, Heiko Liesegang, Axel Strittmatter, Gerhard Gottschalk & Rainer Borriss

doi:10.1038/nbt1325

Abstract - Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium : Bacillus amyloliquefaciens: FZB42 | Full Text - Comparative analysis of the complete genome sequence of the plant growth–promoting bacterium Bacillus amyloliquefaciens FZB42 | PDF (466 KB) - Comparative analysis of the complete genome sequence of the plant growth–promoting bacterium Bacillus amyloliquefaciens FZB42 | Supplementary information

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts - pp1015 - 1024

Michael A Laflamme, Kent Y Chen, Anna V Naumova, Veronica Muskheli, James A Fugate, Sarah K Dupras, Hans Reinecke, Chunhui Xu, Mohammad Hassanipour, Shailaja Police, Chris O'Sullivan, Lila Collins, Yinhong Chen, Elina Minami, Edward A Gill, Shuichi Ueno, Chun Yuan, Joseph Gold & Charles E Murry

doi:10.1038/nbt1327

Abstract - Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Full Text - Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | PDF (863 KB) - Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Supplementary information

See also: News and Views by Rubart & Field

Prospective identification of myogenic endothelial cells in human skeletal muscle - pp1025 - 1034

Bo Zheng, Baohong Cao, Mihaela Crisan, Bin Sun, Guangheng Li, Alison Logar, Solomon Yap, Jonathan B Pollett, Lauren Drowley, Theresa Cassino, Burhan Gharaibeh, Bridget M Deasy, Johnny Huard & Bruno Péault

doi:10.1038/nbt1334

Abstract - Prospective identification of myogenic endothelial cells in human skeletal muscle | Full Text - Prospective identification of myogenic endothelial cells in human skeletal muscle | PDF (795 KB) - Prospective identification of myogenic endothelial cells in human skeletal muscle | Supplementary information

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors - pp1035 - 1044

Marcus Bantscheff, Dirk Eberhard, Yann Abraham, Sonja Bastuck, Markus Boesche, Scott Hobson, Toby Mathieson, Jessica Perrin, Manfred Raida, Christina Rau, Valérie Reader, Gavain Sweetman, Andreas Bauer, Tewis Bouwmeester, Carsten Hopf, Ulrich Kruse, Gitte Neubauer, Nigel Ramsden, Jens Rick, Bernhard Kuster & Gerard Drewes

doi:10.1038/nbt1328

Abstract - Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors | Full Text - Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors | PDF (1,042 KB) - Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors | Supplementary information

See also: News and Views by White

High-frequency generation of viable mice from engineered bi-maternal embryos - pp1045 - 1050

Manabu Kawahara, Qiong Wu, Nozomi Takahashi, Shinnosuke Morita, Kaori Yamada, Mitsuteru Ito, Anne C Ferguson-Smith & Tomohiro Kono

doi:10.1038/nbt1331

First paragraph - High-frequency generation of viable mice from engineered bi-maternal embryos | Full Text - High-frequency generation of viable mice from engineered bi-maternal embryos | PDF (267 KB) - High-frequency generation of viable mice from engineered bi-maternal embryos | Supplementary information

A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments - pp1051 - 1056

Yougen Li, D Allan Drummond, Andrew M Sawayama, Christopher D Snow, Jesse D Bloom & Frances H Arnold

doi:10.1038/nbt1333

First paragraph - A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments | Full Text - A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments | PDF (275 KB) - A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments | Supplementary information

Erratum: Critics pan timid European response to TeGenero disaster - p1057

Peter Mitchell

doi:10.1038/nbt0907-1057a

Full Text - Erratum: Critics pan timid European response to TeGenero disaster | PDF (54 KB) - Erratum: Critics pan timid European response to TeGenero disaster

Erratum: Tech transfer fails to translate into startups - p1057

Stacy Lawrence

doi:10.1038/nbt0907-1057b

Full Text - Erratum: Tech transfer fails to translate into startups | PDF (54 KB) - Erratum: Tech transfer fails to translate into startups

Managing change in biotech: setbacks and failures - p1059

Mary Ann Rafferty

doi:10.1038/nbt0907-1059

Abstract - Managing change in biotech: setbacks and failures | Full Text - Managing change in biotech: setbacks and failures | PDF (71 KB) - Managing change in biotech: setbacks and failures

People - p1060

doi:10.1038/nbt0907-1060

Full Text - People | PDF (77 KB) - People